Vertex Pharmaceuticals Change in Accounts Receivable 2010-2025 | VRTX
Vertex Pharmaceuticals change in accounts receivable for the twelve months ending March 31, 2025 was $-0.554B, a 4.75% increase year-over-year.
- Vertex Pharmaceuticals annual change in accounts receivable for 2024 was $-0.099B, a 18.07% increase from 2023.
- Vertex Pharmaceuticals annual change in accounts receivable for 2023 was $-0.084B, a 76.55% decline from 2022.
- Vertex Pharmaceuticals annual change in accounts receivable for 2022 was $-0.359B, a 30.54% increase from 2021.